Cargando…

Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities

Despite improvements in our understanding of the molecular basis of acute myeloid leukemia (AML), the association between genetic mutations with morphological dysplasia remains unclear. In this study, we evaluated and scored dysplasia in bone marrow (BM) specimens from 168 patients with de novo AML;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weinberg, Olga K., Gibson, Christopher J., Blonquist, Traci M., Neuberg, Donna, Pozdnyakova, Olga, Kuo, Frank, Ebert, Benjamin L., Hasserjian, Robert P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865424/ https://www.ncbi.nlm.nih.gov/pubmed/29326119 http://dx.doi.org/10.3324/haematol.2017.181842

Ejemplares similares

Presence but not number of secondary type mutations influences outcome in de novo AML without MDS‐associated or recurring cytogenetic abnormalities
por: Weinberg, Olga K., et al.
Publicado: (2023)

The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
por: Eisfeld, A-K, et al.
Publicado: (2017)

Cytogenetic Profile of de novo Acute Myeloid Leukemia Patients in Malaysia
por: Meng, Chin Yuet, et al.
Publicado: (2013)

Cytogenetic Characteristics of de novo Acute Myeloid Leukemia in Southern Vietnam
por: Thao, Lai Thi Thanh, et al.
Publicado: (2023)

Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells
por: Ouseph, Madhu M., et al.
Publicado: (2020)

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
por: Weinberg, Olga K., et al.
Publicado: (2022)

Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality
por: Rai, Shinya, et al.
Publicado: (2019)

Age-specific incidence rates for cytogenetically-defined subtypes of acute myeloid leukaemia
por: Moorman, A V, et al.
Publicado: (2002)

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults
por: Tsui, Sze P., et al.
Publicado: (2020)

Age and cytogenetic abnormalities()
por: Souza, Cármino Antonio de
Publicado: (2018)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
por: Gupta, Monika, et al.
Publicado: (2015)

Cytogenetic abnormalities, WHO classification, and evolution of children and adolescents with acute myeloid leukemia
por: Nunes, Amanda de Lourdes, et al.
Publicado: (2019)

Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment–Related Symptoms: Secondary Analysis of a Randomized Controlled Trial
por: Knoerl, Robert, et al.
Publicado: (2019)

Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy
por: Shahjahani, Mohammad, et al.
Publicado: (2015)

Patient-reported symptom distress, and most bothersome issues, before and during cancer treatment
por: Hong, Fangxin, et al.
Publicado: (2016)

Cytogenetic and Morphological Analysis of De Novo Acute Myeloid Leukemia in Adults: A Single Center Study in Jordan
por: Ayesh, MH, et al.
Publicado: (2012)

Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures
por: Wong, Waihay J., et al.
Publicado: (2019)

Cytogenetic abnormalities in Langerhans cell histiocytosis.
por: Betts, D. R., et al.
Publicado: (1998)

Rare Cytogenetic Abnormalities in Myelodysplastic Syndromes
por: Bacher, Ulrike, et al.
Publicado: (2015)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
por: Zahid, Mohammad Faizan, et al.
Publicado: (2017)

Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans
por: Aïssata, Tolo Diebkilé, et al.
Publicado: (2013)

Rare cytogenetic abnormalities in acute myeloid leukemia transformed from Fanconi anemia – a case report
por: Hussain, Shabneez, et al.
Publicado: (2013)

The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia
por: Crisan, AM, et al.
Publicado: (2015)

Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemia
por: Løhmann, Ditte J. A., et al.
Publicado: (2019)

Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
por: Jamieson, Catriona, et al.
Publicado: (2015)

Chemoresponse of de novo Acute Myeloid Leukemia to “7+3” Induction can Be Predicted by c-Myc-facilitated Cytogenetics
por: Hsiao, Tzu-Hung, et al.
Publicado: (2021)

AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics
por: Fuhrmann, Irene, et al.
Publicado: (2022)

Complex cytogenetic abnormalities in chronic myeloid leukemia resulting in early progression to blast crisis: a case report
por: Malakzai, Haider Ali, et al.
Publicado: (2020)

Extended homozygosity is not usually due to cytogenetic abnormality
por: Curtis, David
Publicado: (2007)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Cytogenetic Abnormalities Found in Patients with Reproductive Problems
por: Mackic-Djurovic, Mirela, et al.
Publicado: (2017)

Molecular diagnosis of cytogenetic abnormalities in patients with schizophrenia
por: Bar Shai, M., et al.
Publicado: (2022)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Follow-up of the tumor load in patients with de novo chronic myeloid leukemia and in complete cytogenetic remission treated with imatinib in Colombia
por: Guevara, Gonzalo, et al.
Publicado: (2012)

Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations
por: Akram, Afia Muhammad, et al.
Publicado: (2021)

Characterizing the Molecular Abnormalities in Rare De Novo Ph(+) Acute Myeloid Leukemia
por: Chao, Hong-Ying, et al.
Publicado: (2018)

Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics
por: Berry, Donna L, et al.
Publicado: (2015)

Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes
por: Chaubey, Rekha, et al.
Publicado: (2011)

Automated Deep Learning-Based Diagnosis and Molecular Characterization of Acute Myeloid Leukemia using Flow Cytometry
por: Lewis, Joshua E., et al.
Publicado: (2023)

Prognosis and outcome of patients with acute myeloid leukemia based on FLT3-ITD mutation with or without additional abnormal cytogenetics
por: Tao, Shandong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ckfgeunj7sct47dvqsfsc6eicn